Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.46 |
| ▸ | FABP4 | P15090 | 1/20 | 0.46 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.46 |
| ▸ | CDC25B | P30305 | 1/20 | 0.41 |
| ▸ | MYC | P01106 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | PRKDC | P78527 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.38 |
| ▸ | PIK3CB | P42338 | 3/20 | 0.38 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.38 |
| ▸ | BRD4 | O60885 | 2/20 | 0.38 |
| ▸ | BRD2 | P25440 | 2/20 | 0.38 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | PDE2A | O00408 | 1/20 | 0.38 |
| ▸ | PIK3C2A | O00443 | 1/20 | 0.38 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.38 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20174024 | 0.89 | ALDH1A1 (0.52) | FABP4ALDH1A1KDM4ESMN1; SMN2TP53 | |
| SCHEMBL15852946 | 0.89 | KDM4E (0.52) | CDC25BALDH1A1PRKDCKDM4EPIK3CD | |
| SCHEMBL24171350 | 0.88 | PDE5A (0.43) | FABP3FABP4FABP5CDC25BALDH1A1 | |
| SCHEMBL4080117 | 0.87 | ALOX5 (0.46) | FABP3FABP4FABP5CDC25BMYC | |
| SCHEMBL16858257 | 0.86 | KDM4E (0.44) | CDC25BALDH1A1PRKDCKDM4EPIK3CD | |
| SCHEMBL11713826 | 0.84 | PRKDC (0.47) | ALDH1A1PRKDCKDM4EPIK3CDPIK3CA | |
| SCHEMBL26367015 | 0.83 | FABP3 (0.43) | FABP3FABP4FABP5CDC25BMYC | |
| SCHEMBL30366798 | 0.82 | FABP3 (0.40) | FABP3FABP4FABP5CDC25BMYC | |
| SCHEMBL20317141 | 0.82 | SIRT2 (0.42) | FABP3FABP4FABP5CDC25BALDH1A1 | |
| SCHEMBL23772350 | 0.82 | ALDH1A1 (0.38) | CDC25BALDH1A1PRKDCKDM4EPIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-10428090-B2 | Condensed-cyclic compound and organic light-emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-10-01 | — | — | US | disclosed |
| EP-3006436-B1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2018-12-05 | — | — | EP | disclosed |
| US-9923147-B2 | Organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-20 | — | — | US | disclosed |
| US-9856243-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-02 | — | — | US | disclosed |
| US-20160329501-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| EP-3006436-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2016-04-13 | — | — | EP | disclosed |
| US-20160099423-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-07 | — | — | US | disclosed |
| US-9293712-B2 | Disubstituted pyrene compounds with amino group containing ortho aryl group and devices containing the same | UNIVERSAL DISPLAY CORPORATION (US) | 2016-03-22 | — | — | US | disclosed |
| US-20150102321-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2015-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10428090-B2 | Condensed-cyclic compound and organic light-emitting device comprising the same | C9, C1S, CCNL2 | FABP3 4821/4885FABP4 4485/4885FABP5 4819/4885 |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | C1S, CCNT1, C9 | FABP3 4840/4885FABP4 4282/4885FABP5 4817/4885 |
| US-20160099423-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, MCM4 | FABP3 4779/4885FABP4 3954/4885FABP5 4599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.